(Q37931374)

25 August 2017

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force (English)

1 reference

amyotrophic lateral sclerosis

25 August 2017

0 references

author

Orla Hardiman

8

1 reference

25 August 2017

5

Mamede de Carvalho

1 reference

25 August 2017

Philip Van Damme

7

0 references

Karen E Morrison

Karen E Morrison

10

0 references

Adriano Chiò

Adriano Chio

6

0 references

Vincenzo Silani

Vincenzo Silani

13

0 references

Gian Domenico Borasio

Gian D Borasio

4

0 references

Peter M Andersen

2

Peter M Andersen

1 reference

25 August 2017

Pierre-François Pradat

12

Pierre-Francois Pradat

1 reference

25 August 2017

11

Susanne Petri

1 reference

25 August 2017

14

Barbara Tomik

1 reference

25 August 2017

EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:

1

1 reference

25 August 2017

Sharon Abrahams

3

1 reference

25 August 2017

Katja Kollewe

9

1 reference

25 August 2017

Maria Wasner

15

1 reference

25 August 2017

Markus Weber

16

1 reference

25 August 2017

14 September 2011

1 reference

European Journal of Neurology

25 August 2017

1 reference

25 August 2017

19

1 reference

25 August 2017

3

1 reference

25 August 2017

360-375

1 reference

EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Epidemiology of motor neuron disease in northern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Getting the diagnosis right: beyond El Escorial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Epidemiology of ALS in Italy: a 10-year prospective population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Diagnostic dilemmas in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Good practice in the management of adults with malignant cerebral glioma: clinical guidelines. Working Group, Royal College of Physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Management of motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Effect of referral bias on assessing survival in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The amyotrophic lateral sclerosis center: a model of multidisciplinary management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The importance of a respiratory therapist in the ALS clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Multidisciplinary ALS care improves quality of life in patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Quality of life for ventilator-dependent ALS patients and their caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The effect of noninvasive ventilation on ALS patients and their caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Sexuality in patients with amyotrophic lateral sclerosis and their partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The course of the terminal phase in patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Grief support for informal caregivers of patients with ALS: a national survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Lasting impact in families after death from ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

An analysis of extended survival in patients with amyotrophic lateral sclerosis treated with riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Audit of outcomes in motor neuron disease (MND) patients treated with riluzole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A survey of clinicians' practice in the symptomatic treatment of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Reduction of salivary flow with transdermal scopolamine: a four-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The control of oral secretions in bulbar ALS/MND.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Pathologic laughter and crying in ALS: a search for their origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Emotional Lability in MND: Relationship to cognition and psychopathology and impact on caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Assessment: symptomatic treatment for muscle cramps (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Anxiety undermines quality of life in ALS patients and caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Prevalence of depression in a 12-month consecutive sample of patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Fatigue in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Venous thrombosis in an ALS population over four years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The use of alternative medicine by patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Cerebrospinal fluid filtration in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A Phase I safety study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Motor cortex stimulation for ALS: a double blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Nocturnal pulse oximetry: a new approach to establish the appropriate time for non‐invasive ventilation in ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Non-invasive ventilation in ALS: current practice and future role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A systematic review of the use of opioids in the management of dyspnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Nutritional assessment and survival in ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Nutritional management in MND/ALS patients: an evidence based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Entristar skin-level gastrostomy tube: primary placement with radiologic guidance in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Nasogastric feeding in the management of severe dysphagia in motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A prospective cohort study of neuropsychological test performance in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Cognitive impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Prevalence and patterns of cognitive impairment in sporadic ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Cognitive change in ALS: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Behaviour in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Inferring thought and action in motor neurone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Frontotemporal white matter changes in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Penn State screen exam for the detection of frontal and temporal dysfunction syndromes: application to ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

A screening assessment of cognitive impairment in patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Language impairment in motor neurone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Palliative care in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Promoting excellence in end-of-life care in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Breaking the news: A survey of ALS patients and their caregivers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Diaphragm Training in Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Enteral and parenteral nutrition in the later stages of ALS: An observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: A French national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03501.X

10.1111/J.1468-1331.2011.03501.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference